ams-OSRAM AG header image

ams-OSRAM AG

AMS

Equity

ISIN AT0000A3EPA4 / Valor 137918297

SIX Swiss Exchange (2026-06-05)
CHF 17.23-14.3%

ams-OSRAM AG
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

ams-OSRAM AG is a leading global provider of advanced light and sensor solutions, with a rich history spanning over a century. The company is headquartered in Premstaetten, Austria, and Munich, Germany, and employs approximately 20,000 people worldwide. ams-OSRAM specializes in semiconductor-based light emitters, sensors, CMOS integrated circuits, and software, as well as traditional lighting technologies tailored for automotive and special applications. The company's innovations are pivotal in various sectors, including automotive, industrial, medical, and consumer electronics, where they set industry standards. With a strong focus on digitalization, smart living, energy efficiency, and sustainability, ams-OSRAM leverages its extensive portfolio of around 13,000 patents and patent applications to drive transformative applications. In 2023, the company reported revenues of EUR 3.6 billion, underscoring its significant impact and leadership in the global market.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (20.05.2026):

ams-OSRAM AG — Q4 2025: The company reported Q4 2025 revenues of EUR 874 m with an adjusted EBITDA margin of 18.4% (above the midpoint of guidance) and delivered EUR 144 m of free cash flow for FY25. FY25 revenue was EUR 3,323 m with an 18.3% adjusted EBITDA margin (+150 bps year‑over‑year). Management reached prior “Re-establish the Base” savings ahead of schedule, announced a EUR 200 m ‘Simplify’ transformation program targeting additional run‑rate savings by FY28, and executed strategic divestments and capital actions to sharpen the balance sheet and fund the company’s focus on Digital Photonics.

Q4 2025 results

Revenues EUR 874 m; adjusted EBITDA margin 18.4%, above midpoint of guidance; semiconductor core like‑for‑like growth +8% year‑over‑year (constant FX).

FY25 performance

Full-year revenue EUR 3,323 m; adjusted EBITDA margin 18.3% (+150 bps YoY); semiconductor core like‑for‑like growth +7% YoY (constant FX); all‑time high semiconductor design wins > EUR 5 bn in 2025.

Free cash flow

Reported FCF EUR 144 m for FY25 (adjusted/excluding extraordinary IAS 19 inflows where noted).

Cost savings achieved

“Re‑establish the Base” target achieved one year ahead of plan with ~EUR 220 m run‑rate savings realized.

‘Simplify’ transformation program

New program targets an additional EUR 200 m run‑rate savings by FY28 and will affect ~2,000 employees (approximately half in Europe).

Strategic divestments and balance‑sheet moves

Announced sale of the non‑optical sensor business to Infineon for EUR 570 m cash (closed 3 Feb 2026) and a EUR 200 m partial repurchase of the 2027 convertible bond (16 Jan 2026); pro‑forma leverage cited at ~2.5x considering ~EUR 670 m cash inflows from divestments.

Outlook Q1 2026 and FY26

Q1 2026 guidance: revenues ~EUR 760 m, adjusted EBITDA margin ~15% ±1.5% (assumes EUR/USD 1.19) and typical seasonality/deconsolidation impacts. FY26: management expects modest YoY revenue softening and EBITDA headwinds from divestment‑related one‑offs, stranded costs and higher precious‑metal prices.

Long‑term ambition

Positioning as a Digital Photonics leader with new 2030 financial targets: Semiconductor mid‑to‑high single‑digit revenue CAGR and ≥25% adjusted EBITDA; Group FCF > EUR 200 m and leverage ratio <2.

Summarized from source with an LLMView Source

Key figures

97.8%1Y
-52.8%3Y
-83.3%5Y

Performance

69.6%1Y
73.8%3Y
65.5%5Y

Volatility

Market cap

2139 M

Market cap (USD)

Daily traded volume (Shares)

1,503,792

Daily traded volume (Shares)

1 day high/low

6.3 / 5.852

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
5.00
Nature:
starstarstarstarstar
4.00
Andrea T
Switzerland, 15 Apr 2025
star star star star star
Aktuell gut performend, nürzlich für die Gesellschaft und da nach europ. Standards auch nach aktueller Umweltpolitik.

EQUITIES OF THE SAME SECTOR

Oracle Corp
Oracle Corp Oracle Corp Valor: 959184
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-9.59%USD 213.68
Enovix Corporation
Enovix Corporation Enovix Corporation Valor: 112661858
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-12.92%USD 7.28
QXO Inc
QXO Inc QXO Inc Valor: 135786409
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.90%USD 15.76
Meta Platforms Inc
Meta Platforms Inc Meta Platforms Inc Valor: 14917609
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.51%USD 593.00
Alphabet Inc
Alphabet Inc Alphabet Inc Valor: 29798540
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.98%USD 368.53
Apple Inc
Apple Inc Apple Inc Valor: 908440
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.25%USD 307.34
Cloudflare Inc
Cloudflare Inc Cloudflare Inc Valor: 49563753
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.90%USD 250.11
QuantumScape Corporation
QuantumScape Corporation QuantumScape Corporation Valor: 58478497
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-15.53%USD 7.67
Sarepta Therapeutics Inc
Sarepta Therapeutics Inc Sarepta Therapeutics Inc Valor: 19028527
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.46%USD 15.75
Neurocrine Biosciences Inc
Neurocrine Biosciences Inc Neurocrine Biosciences Inc Valor: 149044
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.07%USD 163.88